These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12370058)

  • 1. Structure, function and modulation of chemokine receptors: members of the g-protein-coupled receptor superfamily.
    Huang Z
    Mini Rev Med Chem; 2002 Aug; 2(4):373-83. PubMed ID: 12370058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Analysis of Chemokine Receptor-Ligand Interactions.
    Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
    J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors implications for HIV-1 coreceptor function.
    Efremov R; Truong MJ; Darcissac EC; Zeng J; Grau O; Vergoten G; Debard C; Capron A; Bahr GM
    Eur J Biochem; 1999 Aug; 263(3):746-56. PubMed ID: 10469138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.
    Rajagopalan L; Rajarathnam K
    Biosci Rep; 2006 Oct; 26(5):325-39. PubMed ID: 17024562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ; Crown SE; Handel TM
    Annu Rev Immunol; 2007; 25():787-820. PubMed ID: 17291188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering chemokines to develop optimized HIV inhibitors.
    Hartley O; Offord RE
    Curr Protein Pept Sci; 2005 Jun; 6(3):207-19. PubMed ID: 15974948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptors--future therapeutic targets for HIV?
    Proudfoot AE; Wells TN; Clapham PR
    Biochem Pharmacol; 1999 Mar; 57(5):451-63. PubMed ID: 9952309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors.
    Monteclaro FS; Arai H; Charo IF
    Methods Enzymol; 1997; 288():70-84. PubMed ID: 9356988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
    Paterlini MG
    Biophys J; 2002 Dec; 83(6):3012-31. PubMed ID: 12496074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
    Zhou N; Luo Z; Hall JW; Luo J; Han X; Huang Z
    Eur J Immunol; 2000 Jan; 30(1):164-73. PubMed ID: 10602038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy.
    Miles TF; Spiess K; Jude KM; Tsutsumi N; Burg JS; Ingram JR; Waghray D; Hjorto GM; Larsen O; Ploegh HL; Rosenkilde MM; Garcia KC
    Elife; 2018 Jun; 7():. PubMed ID: 29882741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
    Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
    Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches to human immunodeficiency virus: structural studies on G-protein-coupled receptors.
    Marshall GR
    Pharmacol Ther; 1997; 76(1-3):135-9. PubMed ID: 9535175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor.
    Martín-Martínez M; Marty A; Jourdan M; Escrieut C; Archer E; González-Muñiz R; García-López MT; Maigret B; Herranz R; Fourmy D
    J Med Chem; 2005 Jul; 48(15):4842-50. PubMed ID: 16033264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemokine receptors and HIV-1 infection].
    Hieshima K; Yoshie O
    Nihon Rinsho; 2002 Apr; 60(4):681-7. PubMed ID: 11968773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of interleukin-8 receptor beta and analysis of the receptor-ligand interaction.
    Luo Z; Butcher DJ; Huang Z
    Protein Eng; 1997 Sep; 10(9):1039-45. PubMed ID: 9464567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
    Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
    J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors.
    Rosenkilde MM; Schwartz TW
    Curr Top Med Chem; 2006; 6(13):1319-33. PubMed ID: 16918451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.